The Department of Homeland Security Science and Technology Directorate awarded a firm-fixed-price contract valued at $1,656,989.53 to Silver Lake Research Corporation, a for-profit organization and manufacturer of goods, for the rapid detection of high-priority foreign animal pathogens using enzyme-linked immunosorbent assay (ELISA)-derived hyperspecific monoclonal antibodies. This contract, which does not have a set-aside designation, is for the development of rapid testing innovations,...
This is a $599,999.40 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to Silver Lake Research Corporation, doing business as Silver Lake Research Corp. The contract is for the development of EAP-derived monoclonal antibodies for phenotyping immune cells of animal models of disease. This work supports infectious disease research and response programs. The contract does not have a...
This is a Cost Plus Fixed Fee contract awarded by the U.S. Department of Homeland Security (DHS) Science and Technology Directorate to Silver Lake Research Corporation, a small business, for research and development services related to the generation, validation, and characterization of new monoclonal antibodies reactive with a group of toxins. The contract has a ceiling value of $1,167,200.00 and an ultimate completion date of December 31, 2019. This award does not have a set-aside designation....
This is a federal contract awarded by the U.S. Department of Homeland Security (DHS) Science and Technology Directorate to Silver Lake Research Corporation, a for-profit small business manufacturer. The $999,169.20 cost-plus-fixed-fee contract is for research and development services to create and validate small molecule select agent toxin detection assays. The contract has an ultimate completion date of July 21, 2020 and was awarded on December 31, 2015. This contract is not set aside for any...
Silver Lake Research Corporation, doing business as Silver Lake Research Corp., has been awarded a firm fixed price definitive contract valued at $600,000 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this contract, Silver Lake will deliver EAP-derived monoclonal antibodies for immune targets involved in cell activation in hamsters, as requested in the original solicitation. The prime contractor will perform work in Irwindale, California....
This is a $717,999.84 cost plus fixed fee contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Qoolabs Inc., a self-certified small disadvantaged, woman-owned business. The contract was awarded under the Small Business Innovation Research (SBIR) Phase II program, which provides funding to small businesses for the research and development of innovative technologies. Under this contract, Qoolabs Inc. will conduct research and development...
This is a $24,617.45 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to Meso Scale Diagnostics LLC, a for-profit limited liability company. The contract is for screening monoclonal antibodies against proteins of interest, with a period of performance through July 31, 2024. No small business set-aside was used. Meso Scale Diagnostics is an...
This federal contract award was made by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery, for the provision of lab supplies. The $149,684 firm fixed-price purchase order does not utilize a set-aside and has an ultimate completion date of December 30, 2015. Meso Scale Diagnostics is a small business that specializes in assay development, laboratory testing equipment, immunoassays, and...
This is a $376,942.12 definitive federal contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Solomon Park Research Laboratories, Inc., a for-profit, veteran-owned business. The contract is for the delivery of laboratory supplies, specifically standardized reference materials, pooled plasma products, testing serum, laboratory equipment, and bulk serum. The contract does not have a set-aside designation. Through this contract, Solomon...
This is a $147,037.50 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Solomon Park Research Laboratories, Inc., a veteran-owned biotechnology company. The contract, which has no set-aside designation, is for the delivery of standardized reference materials, pooled plasma products, testing serum, laboratory equipment, and bulk serum to support the CDC's disease testing and research efforts related to the development of laboratory standards....